Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy
- PMID: 2033400
- DOI: 10.1016/0022-510x(91)90039-a
Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy
Abstract
Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive disorder of muscle in children. The DMD gene product, "dystrophin", is absent from DMD, while the allelic disease, Becker muscular dystrophy (BMD), exhibits dystrophin of abnormal size and/or quantity. But we are still uncertain about the scenario that internally deleted (or duplicated) dystrophin in BMD possesses its carboxy (C)-terminal region, and severely truncated dystrophin in DMD does not. Here we use a new monoclonal antibody directed against an peptide in the C-terminal end of the dystrophin molecule to show that the C-terminus is preserved in 30 BMD and 24 control skeletal muscles but not in 21 DMD specimens. This result, taken together with data on deletions of the dystrophin gene, emphasizes both the diagnostic and biological importance of the C-terminal domain which is required for proper function and stability of dystrophin, and substantiates the validity of the reading frame hypothesis for DMD versus BMD deletions on a biochemical level.
Similar articles
-
Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.Hum Mol Genet. 1993 Jun;2(6):737-44. doi: 10.1093/hmg/2.6.737. Hum Mol Genet. 1993. PMID: 8353493
-
Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein.J Neurol Sci. 1991 Feb;101(2):141-7. doi: 10.1016/0022-510x(91)90038-9. J Neurol Sci. 1991. PMID: 1709683
-
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.Am J Hum Genet. 1989 Oct;45(4):498-506. Am J Hum Genet. 1989. PMID: 2491009 Free PMC article.
-
Unraveling the mysteries of Duchenne and Becker muscular dystrophy.Mol Chem Neuropathol. 1989 Feb;10(1):15-20. doi: 10.1007/BF02969482. Mol Chem Neuropathol. 1989. PMID: 2660836 Review.
-
[Molecular genetics and problems found in genetic diagnosis of Duchenne Becker muscular dystrophy].Nihon Rinsho. 1997 Dec;55(12):3120-5. Nihon Rinsho. 1997. PMID: 9436421 Review. Japanese.
Cited by
-
Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.Am J Hum Genet. 1993 Jun;52(6):1057-66. Am J Hum Genet. 1993. PMID: 7684887 Free PMC article.
-
Deletions in the 5' region of dystrophin and resulting phenotypes.J Med Genet. 1994 Nov;31(11):843-7. doi: 10.1136/jmg.31.11.843. J Med Genet. 1994. PMID: 7853367 Free PMC article.
-
A novel biomarker of fibrofatty replacement in dystrophinopathies identified by integrating transcriptome, magnetic resonance imaging, and pathology data.J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):98-111. doi: 10.1002/jcsm.13410. Epub 2023 Dec 26. J Cachexia Sarcopenia Muscle. 2024. PMID: 38146684 Free PMC article.
-
Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy.Arch Dis Child. 1993 May;68(5):632-6. doi: 10.1136/adc.68.5.632. Arch Dis Child. 1993. PMID: 8323331 Free PMC article.
-
The use of monoclonal antibodies in diagnostic tests for Becker and Duchenne muscular dystrophy.J Neurol. 1993 Jan;240(1):21-4. doi: 10.1007/BF00838441. J Neurol. 1993. PMID: 8423459
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical